343564-56-7

Basic information

• Product Name: 4-BROMO-3-FLUORO-N-METHOXY-N-METHYL-BENZAMIDE
• Synonyms: 4-BROMO-3-FLUORO-N-METHOXY-N-METHYL-BENZAMIDE
• CAS NO: 343564-56-7
• Molecular Formula: C₉H₉BrFNO₂
• Molecular Weight: 262.08
• Mol File: 343564-56-7.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 359°Cat760mmHg
• Flash Point: 170.9°C
• Appearance: /
• Density: 1.528g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.543
• CAS DataBase Reference: 4-BROMO-3-FLUORO-N-METHOXY-N-METHYL-BENZAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-FLUORO-N-METHOXY-N-METHYL-BENZAMIDE(343564-56-7)
• EPA Substance Registry System: 4-BROMO-3-FLUORO-N-METHOXY-N-METHYL-BENZAMIDE(343564-56-7)

Safety Data

• Hazardous Substances Data: 343564-56-7(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H9BrFNO2/c1-12(14-2)9(13)6-3-4-7(10)8(11)5-6/h3-5H,1-2H3

Upstream product

• 695188-21-7 4-bromo-3-fluorobenzoyl chloride 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 153556-42-4 4-bromo-3-fluorobenzoic acid 
• 1117-97-1 N,0-dimethylhydroxylamine 

Downstream Products

• 916792-04-6 1-(4-bromo-3-fluoro-phenyl)-propan-1-one 
• 304445-49-6 1-(4-bromo-3-fluorophenyl)ethan-1-one 
• 343564-57-8 1-(4-bromo-3-fluorophenyl)-1-butanone 
• 956037-85-7 4-bromo-3-fluoro-4'-methylbenzophenone 
• 1022154-78-4 (4-acetyl-2-fluorophenyl)boronic acid 
• 1006875-89-3 1-(4-bromo-3-fluorophenyl)-2,2-dihydroxyethanone 
• 1029714-83-7 2-(4-bromo-3-fluorophenyl)-2-oxoacetaldehyde 
• 1006875-90-6 1-(4-bromo-3-fluorophenyl)-2,2-diethoxyethanone 
• 1029714-84-8 6-(4-bromo-3-fluorophenyl)-1,2,4-triazin-3-amine 
• 1029714-86-0 6-((2-(4-bromo-3-fluorophenyl)imidazo[1,2-b][1,2,4]triazin-7-yl)methyl)quinoline 
• 1029714-87-1 2-fluoro-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzonitrile 
• 1332952-19-8 2-fluoro-N-[(2R)-2-hydroxypropyl]-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide 

Relevant articles and documents

ISO-CITRATE DEHYDROGENASE (IDH) INHIBITOR

Disclosed are compounds inhibiting the conversion of α–KG to D-2-HG, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition c

PIPERIDINE COMPOUNDS AS PCSK9 INHIBITORS

One aspect of the invention relates to a series of new PCSK9 inhibitor compounds comprising piperidine ring structures, including compounds of formula (I) and/or pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating PCSK9 receptor related diseases comprising administration of one or more compounds of formula (I) or a pharmaceutically acceptable salt thereof.

Synthesis method of 3-fluoro-4-bromo-acetophenone

The invention relates to a synthesis method of 3-fluoro-4-bromo-acetophenone. The method includes: taking 3-fluoro-4-bromo-benzoyl chloride, dimethylhydroxyamine hydrochloride and methylmagnesium chloride as the raw materials, carrying out aminolysis, ext